Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wencheng Li

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Journal of Radiosurgery and SBRT|December 18, 2025
External validation of a genomic signature for oligometastatic non-small cell lung cancerAriel R Choi, Ralph B D'Agostino, Claire M Lanier, et al.
Cancer Research|September 9, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung CancerMargaret R Smith, Caroline B Dixon, Yuezhu Wang, et al.
Cell|January 24, 2012
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayWilliam A Freed-Pastor, Hideaki Mizuno, Xi Zhao, et al.
Human Molecular Genetics|October 11, 2023
Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease modelsGrace Liu, Philip Lipari, Anna Mollin, et al.
The American Journal of Pathology|October 29, 2013
CNS inflammation and bone marrow neuropathy in type 1 diabetesPing Hu, Jeffrey S Thinschmidt, Yuanqing Yan, et al.
Frontiers in Endocrinology|October 2, 2024
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastasesAriel R Choi, Ralph B D'Agostino, Michael K Farris, et al.
Cancer Communications (London, England)|June 11, 2026
<i>TGFBR1</i>*6A and Risk for Colorectal CancerAllan M Johansen, Julie T Ziegler, Kojo Agyemang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2016
Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2Soroush Tahmasebi, Seyed Mehdi Jafarnejad, Ingrid S Tam, et al.
Nature Communications|June 8, 2021
A deep learning approach to identify gene targets of a therapeutic for human splicing disordersDadi Gao, Elisabetta Morini, Monica Salani, et al.
Nature Communications|December 16, 2021
Small molecule splicing modifiers with systemic HTT-lowering activityAnuradha Bhattacharyya, Christopher R Trotta, Jana Narasimhan, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Journal of Radiosurgery and SBRT|December 18, 2025
External validation of a genomic signature for oligometastatic non-small cell lung cancerAriel R Choi, Ralph B D'Agostino, Claire M Lanier, et al.
Cancer Research|September 9, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung CancerMargaret R Smith, Caroline B Dixon, Yuezhu Wang, et al.
Cell|January 24, 2012
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayWilliam A Freed-Pastor, Hideaki Mizuno, Xi Zhao, et al.
Human Molecular Genetics|October 11, 2023
Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease modelsGrace Liu, Philip Lipari, Anna Mollin, et al.
The American Journal of Pathology|October 29, 2013
CNS inflammation and bone marrow neuropathy in type 1 diabetesPing Hu, Jeffrey S Thinschmidt, Yuanqing Yan, et al.
Frontiers in Endocrinology|October 2, 2024
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastasesAriel R Choi, Ralph B D'Agostino, Michael K Farris, et al.
Cancer Communications (London, England)|June 11, 2026
<i>TGFBR1</i>*6A and Risk for Colorectal CancerAllan M Johansen, Julie T Ziegler, Kojo Agyemang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2016
Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2Soroush Tahmasebi, Seyed Mehdi Jafarnejad, Ingrid S Tam, et al.
Nature Communications|June 8, 2021
A deep learning approach to identify gene targets of a therapeutic for human splicing disordersDadi Gao, Elisabetta Morini, Monica Salani, et al.
Nature Communications|December 16, 2021
Small molecule splicing modifiers with systemic HTT-lowering activityAnuradha Bhattacharyya, Christopher R Trotta, Jana Narasimhan, et al.
Pageof 17